Azafaros to Present at BIO International Convention 2026

Contributed by: Business Wire

Logo

Tags

Research

Finance

Neurology

Professional Services

Biotechnology

General Health

Pharmaceutical

Health

Science

Other Science

Azafaros

More Like This

Azafaros to Present at BIO International Convention 2025 Following Successful €132M Series B Financing

Azafaros to Present at J.P. Morgan’s 44th Annual Healthcare Conference

Azafaros to Present at J.P. Morgan’s 43rd Annual Healthcare Conference

Azafaros Announces Key Scientific Oral and Poster Presentations on Nizubaglustat Accepted for WORLDSymposium™ 2026

Azafaros Announces Key Scientific Oral and Poster Presentations on Nizubaglustat Accepted for WORLDSymposium™ 2025

Azafaros Announces Publication of Preclinical Efficacy Data with Nizubaglustat in GM2 Gangliosidosis

Azafaros Secures € 132M in Oversubscribed Series B Financing to Advance Phase 3 Clinical Programs of Innovative Therapies in Lysosomal Storage Disorders

Azafaros Announces Initiation of two Global Phase 3 studies with Nizubaglustat in Niemann-Pick disease Type C (NPC) and GM1/GM2 gangliosidoses, respectively